Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer

Jiang Lv(Chinese Academy of Sciences), Peng Li(Chinese Academy of Sciences), Duanqing Pei(Westlake University), Shuzhong Cui(Guangzhou Medical University), Suimin Chen(Guangzhou University of Chinese Medicine), Zixia Liu, Youguo Long(Chinese Academy of Sciences), Suna Wang(Liaocheng University), Qiting Wu(Chinese Academy of Sciences), Zhaoyang Tang(Academy of Medical Sciences), Diwei Zheng(Wuhan University), Ruocong Zhao(Chinese Academy of Sciences), Di Wu(Chinese PLA General Hospital), Yao Yao(Dalian Medical University), Zhenfeng Zhang(Dalian Medical University), Simiao Lin(Chinese Academy of Sciences), Chen Ren(Wuhan University), Yantao Chen(Sun Yat-sen University), Qing He(Sun Yat-sen University), Huihui Yao(Soochow University), Jingxuan Shi(Guangzhou Women and Children Medical Center), Yang Li(Sun Yat-sen University), Xinru Wei(China Energy Engineering Corporation (China)), Zhi Wang(Northwest A&F University), Zhiping Wu(St. Jude Children's Research Hospital), Xuchao Zhang(Guangdong General Hospital), Pentao Liu(Hong Kong Science and Technology Parks Corporation)
Journal of Hematology & Oncology
February 18, 2019
Cited by 141


Related Papers